ACS Pharmacology and Translational Science

ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered. ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition. Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.

ACS Pharmacology and Translational Science已被国际权威数据库SCIE收录，JCR分区：Q1。 ACS Pharmacology and Translational Science出版高质量、创新性和影响力的研究论文，涵盖生物科学的广泛领域，从基础和分子科学到临床前转化研究。涉及新型作用机制的临床研究以及提供创新和推进转化的方法论论文也将被考虑。其优先考虑将基础药理学和/或生物化学研究成果充分整合到生理过程中的研究，这些研究在广泛的生物医学学科中具有转化潜力。因此，本刊特别关注采用体外和体内系统互补的研究。尽管如此，所有具有明确转化意义的创新性和影响力研究都将被考虑。 ACS Pharmacology & Translational Science不发表浓度未知或化学成分未知的生物提取物研究。